SCOPE           

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption for The Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Lateral Epicondylitis (Tennis Elbow) Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Market Key Trends

4.4. Global Lateral Epicondylitis (Tennis Elbow) Leading Company Analysis, 2019

4.5. Porter’s Five Forces Analysis

4.6. Impact of Covid-19 Across Industry

5.    Global Lateral Epicondylitis (Tennis Elbow) Market Overview

5.1. Market Estimates & Forecast by Value, 2016-2026

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.  By Treatment Type

5.2.1.1.       Corticosteroid Injections

5.2.1.2.       Surgery

5.2.1.3.       Therapy (Shock Wave Therapy & Physical Therapy)

5.2.1.4.       Painkillers and NSAIDS

5.2.1.5.       Equipment's and Other Products

5.2.2.  By End User

5.2.2.1.      Hospital/Clinic

5.2.2.2.       Pharmacy/Drug Stores

5.2.3.  By Region

5.2.3.1.       North America

5.2.3.2.       Europe

5.2.3.3.       Asia Pacific

5.2.3.4.       Latin America

5.2.3.5.       Middle East & Africa

6.    North America Lateral Epicondylitis (Tennis Elbow) Market

6.1. Market Estimates & Forecast by Value, 2016-2026

6.1.1.   By Value (USD Million)

6.2. Market Share & Forecast

6.2.1.   By Treatment Type

6.2.2.   By End-User

6.2.3.   By Country

6.2.3.1.       United States

6.2.3.2.       Canada

7.    Europe Lateral Epicondylitis (Tennis Elbow) Market

7.1. Market Estimates & Forecast by Value, 2016-2026

7.1.1.   By Value (USD Million)

7.2. Market Share & Forecast

7.2.1.   By Treatment Type

7.2.2.   By End-User

7.2.3.   By Country

7.2.3.1.       Germany

7.2.3.2.       United Kingdom

7.2.3.3.       France

7.2.3.4.       Italy

7.2.3.5.       Spain

7.2.3.6.       Rest of Europe

8.    Asia Pacific Lateral Epicondylitis (Tennis Elbow) Market

8.1. Market Estimates & Forecast by Value, 2016-2026

8.1.1.   By Value (USD Million)

8.2. Market Share & Forecast

8.2.1.   By Treatment Type

8.2.2.   By End-User

8.2.3.   By Country

8.2.3.1.       China

8.2.3.2.       India

8.2.3.3.       Japan

8.2.3.4.       South Korea

8.2.3.5.       Rest of APAC

9.    Latin America Lateral Epicondylitis (Tennis Elbow) Market

9.1. Market Estimates & Forecast by Value, 2016-2026

9.1.1.   By Value (USD Million)

9.2. Market Share & Forecast

9.2.1.   By Treatment Type

9.2.2.   By End-User

9.2.3.   By Country

9.2.3.1.       Brazil

9.2.3.2.       Mexico

9.2.3.3.       Rest of Latin America

10. Middle East & Africa Lateral Epicondylitis (Tennis Elbow) Market

10.1.             Market Estimates & Forecast by Value, 2016-2026

10.1.1. By Value (USD Million)

10.2.             Market Share & Forecast

10.2.1. By Treatment Type

10.2.2. By End-User

10.2.3. By Country

10.2.3.1.UAE

10.2.3.2.Saudi Arabia

10.2.3.3.South Africa

10.2.3.4.Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

11.1.   Stryker Corporation

11.2.   Smith & Nephew plc

11.3.   Arthrex

11.4.   Zimmer Biomet

11.5.   Seikagaku Corporation

11.6.   DJO Global, Inc.

11.7.   Pfizer Inc.

11.8.   3M Company

11.9.   Chugai Pharmaceutical Co., Ltd

11.10.Teikoku Seiyaku Co., Ltd.

11.11.Other Prominent Players

 

*Financial details in case of unlisted companies will be provided as per data availability.

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable